OTX-2002
omega therapeutics
[]
find us at #gi23 tomorrow! we ll be presenting a poster on the trial design of our phase 1/2 mychelangelo i clinical study evaluating our lead candidate in #hepatocellularcarcinoma (hcc). see the full conference program here: 
Pioneering Epigenomic Programming. Omega Epigenomic Controllers: mRNA therapeutics as programmable epigenetic medicines #PrecisionGenomicControl